These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27303447)

  • 1. IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data.
    Legehar A; Xhaard H; Ghemtio L
    J Cheminform; 2016; 8():33. PubMed ID: 27303447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
    Khan MT; Sylte I
    Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances of Computational Modeling for Predicting Drug Metabolism: A Perspective.
    Kar S; Leszczynski J
    Curr Drug Metab; 2017; 18(12):1106-1122. PubMed ID: 28595533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database.
    Dong J; Wang NN; Yao ZJ; Zhang L; Cheng Y; Ouyang D; Lu AP; Cao DS
    J Cheminform; 2018 Jun; 10(1):29. PubMed ID: 29943074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties.
    Cheng F; Li W; Zhou Y; Shen J; Wu Z; Liu G; Lee PW; Tang Y
    J Chem Inf Model; 2012 Nov; 52(11):3099-105. PubMed ID: 23092397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADMET evaluation in drug discovery. 11. PharmacoKinetics Knowledge Base (PKKB): a comprehensive database of pharmacokinetic and toxic properties for drugs.
    Cao D; Wang J; Zhou R; Li Y; Yu H; Hou T
    J Chem Inf Model; 2012 May; 52(5):1132-7. PubMed ID: 22559792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETM-DB: integrated Ethiopian traditional herbal medicine and phytochemicals database.
    Bultum LE; Woyessa AM; Lee D
    BMC Complement Altern Med; 2019 Aug; 19(1):212. PubMed ID: 31412866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OptADMET: a web-based tool for substructure modifications to improve ADMET properties of lead compounds.
    Yi J; Shi S; Fu L; Yang Z; Nie P; Lu A; Wu C; Deng Y; Hsieh C; Zeng X; Hou T; Cao D
    Nat Protoc; 2024 Apr; 19(4):1105-1121. PubMed ID: 38263521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network analysis of FDA approved drugs and their targets.
    Ma'ayan A; Jenkins SL; Goldfarb J; Iyengar R
    Mt Sinai J Med; 2007 Apr; 74(1):27-32. PubMed ID: 17516560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADMET-score - a comprehensive scoring function for evaluation of chemical drug-likeness.
    Guan L; Yang H; Cai Y; Sun L; Di P; Li W; Liu G; Tang Y
    Medchemcomm; 2019 Jan; 10(1):148-157. PubMed ID: 30774861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling ADMET.
    Ghosh J; Lawless MS; Waldman M; Gombar V; Fraczkiewicz R
    Methods Mol Biol; 2016; 1425():63-83. PubMed ID: 27311462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADMETopt: A Web Server for ADMET Optimization in Drug Design via Scaffold Hopping.
    Yang H; Sun L; Wang Z; Li W; Liu G; Tang Y
    J Chem Inf Model; 2018 Oct; 58(10):2051-2056. PubMed ID: 30251842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADMET-AI: A machine learning ADMET platform for evaluation of large-scale chemical libraries.
    Swanson K; Walther P; Leitz J; Mukherjee S; Wu JC; Shivnaraine RV; Zou J
    bioRxiv; 2023 Dec; ():. PubMed ID: 38234753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries.
    Swanson K; Walther P; Leitz J; Mukherjee S; Wu JC; Shivnaraine RV; Zou J
    Bioinformatics; 2024 Jul; 40(7):. PubMed ID: 38913862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DrugCentral: online drug compendium.
    Ursu O; Holmes J; Knockel J; Bologa CG; Yang JJ; Mathias SL; Nelson SJ; Oprea TI
    Nucleic Acids Res; 2017 Jan; 45(D1):D932-D939. PubMed ID: 27789690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADMET modeling approaches in drug discovery.
    Ferreira LLG; Andricopulo AD
    Drug Discov Today; 2019 May; 24(5):1157-1165. PubMed ID: 30890362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phish-Pharm: A Searchable Database of Pharmacokinetics and Drug Residue Literature in Fish - 2022 Update.
    Crosby TC; Kittel EC; Gieseker CM
    AAPS J; 2022 Oct; 24(6):105. PubMed ID: 36195686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs.
    Ladanie A; Speich B; Naudet F; Agarwal A; Pereira TV; Sclafani F; Martin-Liberal J; Schmid T; Ewald H; Ioannidis JPA; Bucher HC; Kasenda B; Hemkens LG
    Trials; 2018 Sep; 19(1):505. PubMed ID: 30231912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracting Relevant Information from FDA Drug Files to Create a Structurally Diverse Drug Database Using KnowItAll
    D'Souza MJ; Koyoshi F
    Pharm Rev; 2009 May; 7(3):. PubMed ID: 25356090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Approaches in Preclinical Studies on Drug Discovery and Development.
    Wu F; Zhou Y; Li L; Shen X; Chen G; Wang X; Liang X; Tan M; Huang Z
    Front Chem; 2020; 8():726. PubMed ID: 33062633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.